{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T04:48:09Z","timestamp":1786337289549,"version":"build-2736575974"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1378\/chest.14-3006","type":"journal-article","created":{"date-parts":[[2015,3,27]],"date-time":"2015-03-27T11:27:46Z","timestamp":1427455666000},"page":"491-498","source":"Crossref","is-referenced-by-count":8,"title":["Effect of Active Smoking on Comparative Efficacy of Antithrombotic Therapy in Patients With Atrial Fibrillation"],"prefix":"10.1016","volume":"148","author":[{"given":"Denis","family":"Angoulvant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Villejoubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodora","family":"Bejan-Angoulvant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Ivanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Saint Etienne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Fauchier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1378\/chest.14-3006_bib1","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","article-title":"2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association","volume":"33","author":"Camm","year":"2012","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1378\/chest.14-3006_bib2","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1160\/TH12-03-0175","article-title":"The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study","volume":"107","author":"Olesen","year":"2012","journal-title":"Thromb Haemost"},{"issue":"9816","key":"10.1378\/chest.14-3006_bib3","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S0140-6736(11)61514-6","article-title":"Atrial fibrillation","volume":"379","author":"Lip","year":"2012","journal-title":"Lancet"},{"issue":"5","key":"10.1378\/chest.14-3006_bib4","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"issue":"5","key":"10.1378\/chest.14-3006_bib5","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1378\/chest.13-0054","article-title":"Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT2R2 score","volume":"144","author":"Apostolakis","year":"2013","journal-title":"Chest"},{"key":"10.1378\/chest.14-3006_bib6","doi-asserted-by":"crossref","first-page":"f5307","DOI":"10.1136\/bmj.f5307","article-title":"Effect of smoking on comparative efficacy of antiplatelet agents: systematic review, meta-analysis, and indirect comparison","volume":"347","author":"Gagne","year":"2013","journal-title":"BMJ"},{"issue":"23","key":"10.1378\/chest.14-3006_bib7","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"issue":"3","key":"10.1378\/chest.14-3006_bib8","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1378\/chest.13-2976","article-title":"Relationship of the SAMe-TT2R2 score to poor-quality anticoagulation, stroke, clinically relevant bleeding and mortality in patients with atrial fibrillation.","volume":"146","author":"Lip","year":"2014","journal-title":"Chest"},{"issue":"4","key":"10.1378\/chest.14-3006_bib9","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1378\/chest.10-2436","article-title":"Prognosis and guideline-adherent antithrombotic treatment in patients with atrial fibrillation and atrial flutter: implications of undertreatment and overtreatment in real-life clinical practice; the Loire Valley Atrial Fibrillation Project","volume":"140","author":"Gorin","year":"2011","journal-title":"Chest"},{"issue":"4","key":"10.1378\/chest.14-3006_bib10","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1160\/TH12-10-0772","article-title":"General mechanisms of coagulation and targets of anticoagulants (section I). Position paper of the ESC Working Group on Thrombosis\u2014Task Force on Anticoagulants in Heart Disease","volume":"109","author":"De Caterina","year":"2013","journal-title":"Haemost"},{"issue":"6","key":"10.1378\/chest.14-3006_bib11","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1160\/TH13-06-0443","article-title":"Vitamin K antagonists in heart disease: current status and perspectives (section III). Position paper of the ESC Working Group on Thrombosis\u2014Task Force on Anticoagulants in Heart Disease","volume":"110","author":"De Caterina","year":"2013","journal-title":"Thromb Haemost"},{"issue":"10","key":"10.1378\/chest.14-3006_bib12","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1001\/archinte.165.10.1095","article-title":"Systematic overview of warfarin and its drug and food interactions","volume":"165","author":"Holbrook","year":"2005","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1378\/chest.14-3006_bib13","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2165\/00003088-199936060-00004","article-title":"Drug interactions with tobacco smoking. An update","volume":"36","author":"Zevin","year":"1999","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"10.1378\/chest.14-3006_bib14","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1378\/chest.10-0777","article-title":"Assessing evidence of interaction between smoking and warfarin: a systematic review and meta-analysis","volume":"139","author":"Nathisuwan","year":"2011","journal-title":"Chest"},{"issue":"3","key":"10.1378\/chest.14-3006_bib15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/cpt1979253309","article-title":"Smoking and warfarin disposition","volume":"25","author":"Bachmann","year":"1979","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"10.1378\/chest.14-3006_bib16","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1345\/aph.10226","article-title":"Increase in international normalized ratio associated with smoking cessation","volume":"35","author":"Colucci","year":"2001","journal-title":"Ann Pharmacother"},{"issue":"12","key":"10.1378\/chest.14-3006_bib17","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1345\/aph.1E381","article-title":"Search for predictors of nontherapeutic INR results with warfarin therapy.","volume":"39","author":"McGriff-Lee","year":"2005","journal-title":"Ann Pharmacother"},{"issue":"1","key":"10.1378\/chest.14-3006_bib18","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/clc.20175","article-title":"Factors associated with non-adherence to therapy with warfarin in a population of chronic heart failure patients","volume":"31","author":"Pamboukian","year":"2008","journal-title":"Clin Cardiol"},{"issue":"23","key":"10.1378\/chest.14-3006_bib19","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1161\/CIRCULATIONAHA.109.866533","article-title":"Smoking, clopidogrel, and mortality in patients with established cardiovascular disease","volume":"120","author":"Berger","year":"2009","journal-title":"Circulation"},{"key":"10.1378\/chest.14-3006_bib20","doi-asserted-by":"crossref","first-page":"f5909","DOI":"10.1136\/bmj.f5909","article-title":"Smoking status and the effects of antiplatelet drugs","volume":"347","author":"Hirschl","year":"2013","journal-title":"BMJ"},{"issue":"10","key":"10.1378\/chest.14-3006_bib21","first-page":"1569","article-title":"Cigarette smoking inhibits the antiplatelet activity of aspirin in patients with coronary heart disease","volume":"124","author":"Li","year":"2011","journal-title":"Chin Med J (Engl)"},{"issue":"5","key":"10.1378\/chest.14-3006_bib22","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.ahj.2004.08.030","article-title":"Cigarette smoking is associated with increased circulating proinflammatory and procoagulant markers in patients with chronic coronary artery disease: effects of aspirin treatment","volume":"149","author":"Ikonomidis","year":"2005","journal-title":"Am Heart J"},{"issue":"3","key":"10.1378\/chest.14-3006_bib23","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1136\/heartjnl-2013-304138","article-title":"The impact of smoking on clinical efficacy and pharmacodynamic effects of clopidogrel: a systematic review and meta-analysis.","volume":"100","author":"Zhao","year":"2014","journal-title":"Heart"},{"key":"10.1378\/chest.14-3006_bib24","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1741-7015-9-97","article-title":"The \u201csmoker's paradox\u201d in patients with acute coronary syndrome: a systematic review","volume":"9","author":"Aune","year":"2011","journal-title":"BMC Med"},{"issue":"5","key":"10.1378\/chest.14-3006_bib25","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jjcc.2014.07.012","article-title":"Impact of persistent smoking on long-term outcomes in patients with nonvalvular atrial fibrillation","volume":"65","author":"Nakagawa","year":"2015","journal-title":"J Cardiol"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215503450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215503450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T04:55:58Z","timestamp":1537764958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215503450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0012369215503450"],"URL":"https:\/\/doi.org\/10.1378\/chest.14-3006","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]}}}